ScholarIQanswers from OpenAlex & ORCID
Jeffrey P. Krischer
ResearcherPublications, citations & collaboration network
Jeffrey P. Krischer is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jeffrey P. Krischer have?
ScholarIQindexed works
Jeffrey P. Krischer has 617 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jeffrey P. Krischer have?
ScholarIQcitation count
Jeffrey P. Krischer has 38,699 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jeffrey P. Krischer?
ScholarIQh-index
Jeffrey P. Krischer has an h-index of 104 in OpenAlex.
What is the i10-index of Jeffrey P. Krischer?
ScholarIQi10-index
Jeffrey P. Krischer has an i10-index of 359 in OpenAlex.
What is the ORCID of Jeffrey P. Krischer?
ScholarIQorcid
The ORCID for Jeffrey P. Krischer is on the source record.
What is the OpenAlex record for Jeffrey P. Krischer?
ScholarIQopenalex
The OpenAlex for Jeffrey P. Krischer is on the source record.
What are the most-cited papers on Jeffrey P. Krischer?
ScholarIQmost cited works
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
Richard A. Insel, Jessica L. Dunne, Mark A. Atkinson, Jane L. Chiang, Dana Dabelea, Peter A. Gottlieb, Carla J. Greenbaum, Kevan C. Herold, Jeffrey P. Krischer, Åke Lernmark, Robert E. Ratner, Marian Rewers, Desmond Schatz, Jay S. Skyler, Jay M. Sosenko, Anette‐G. Ziegler
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
Kevan C. Herold, Brian N. Bundy, S. Alice Long, Jeffrey A. Bluestone, Linda A. DiMeglio, Matthew J. Dufort, Stephen E. Gitelman, Peter A. Gottlieb, Jeffrey P. Krischer, Peter S. Linsley, Jennifer B. Marks, Wayne D. Moore, Antoinette Moran, Henry Rodriguez, William E. Russell, Desmond Schatz, Jay S. Skyler, Eva Tsalikian, Diane K. Wherrett, Anette-Gabriele Ziegler, Carla J. Greenbaum
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
Tihamer Orban, Brian N. Bundy, Dorothy J. Becker, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Carla J. Greenbaum, Jennifer B. Marks, Roshanak Monzavi, Antoinette Moran, Philip Raskin, Henry Rodriguez, William E. Russell, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler
International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases
Kym M. Boycott, Ana Rath, Jessica X. Chong, Taila Hartley, Fowzan S. Alkuraya, Gareth Baynam, Anthony J. Brookes, Michael Brudno, Ãngel Carracedo, Johan T. den Dunnen, Stephanie O. M. Dyke, Xavier Estivill, Jack Goldblatt, Catherine Gonthier, Stephen C. Groft, Marta Gut, Ada Hamosh, Philip Hieter, Sophie Höhn, Matthew E. Hurles, Petra Kaufmann, Bartha Maria Knoppers, Jeffrey P. Krischer, Milan Maçek, Gert Matthijs, Annie Olry, Samantha Parker, Justin Paschall, Anthony Philippakis, Heidi L. Rehm, Peter N. Robinson, Pak C. Sham, Румен Стефанов, Domenica Taruscio, Divya Unni, Megan R. Vanstone, Feng Zhang, Han G. Brunner, Michael J. Bamshad, Hanns Lochmüller
Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer
Maya Guglin, Jeffrey P. Krischer, Roy Tamura, Angelina Fink, Lauren Bello-Matricaria, Worta McCaskill‐Stevens, Pamela N. Münster